To confirm that these results are applicable to different GBM cell lines, we mutated the MSH6 gene (knockout, KO) in U87MG and LNZ308 GBM cells using CRISPR/Cas9 and applied the same treatments to the control and resulting MSH6-KO cells. The gene discussed is MSH6; the disease is glioblastoma.